Results 71 to 80 of about 1,149,511 (200)

A dynamic nomogram predicting symptomatic pneumonia in patients with lung cancer receiving thoracic radiation

BMC Pulmonary Medicine
Purpose The most common and potentially fatal side effect of thoracic radiation therapy is radiation pneumonitis (RP). Due to the lack of effective treatments, predicting radiation pneumonitis is crucial. This study aimed to develop a dynamic nomogram to
Yawen Zha, Jingjing Zhang, Xinyu Yan, Chen Yang, Lei Wen, Minying Li   +5 more
doaj   +1 more source

Diagnosis and treatment of pneumonitis of mixed etiology after complex treatment of stage II non-small cell lung cancer

Клинический разбор в общей медицине
Radiation pneumonitis is one of the most common complications of lung cancer radiotherapy. Its incidence reaches 61%. Immune-mediated pneumonitis in the treatment of pembrolizumab occurs in 9.5% of cases.
Larisa V. Kursova, Anna Yu. Usacheva, Zavir M. Salimov, Sergey A. Ivanov, Sergey A. Ivanov   +4 more
doaj   +1 more source

The Addition of Concurrent Immune Checkpoint Inhibitors for Chemoradiotherapy With Consolidative Immune Checkpoint Inhibitors in Unresectable Cancers: A Systematic Review and Meta‐Analysis

International Journal of Cancer, Volume 159, Issue 9, Page 2262-2277, 1 November 2026.
Currently, there are at least 30 ongoing clinical trials in the enrollment phase to evaluate adding concurrent ICIs to the PACIFIC regimen for a variety of solid tumors. Considering the lack of head‐to‐head comparative studies, this meta‐analysis aims to investigate the differences in efficacy between adding and not adding concurrent ICIs to CRT ...
Xu Tong, Zhenting Liu, Xiaoxiang Zhou, Nan Bi, Yibo Gao   +4 more
wiley   +1 more source

Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis

, 2009
PURPOSE: Radiation pneumonitis is a serious complication that develops after thoracic irradiation. The purpose of this study was to identify prognostic factors for severe radiation pneumonitis in patients with non- small-cell lung cancer.
WANG, JANN-YUAN;CHEN, KUAN-YU;WANG, JANN-TAY;CHEN, JEN-HAU;LIN, JOU-WEI;WANG, HAO-CHIEN;LEE, LI-NA;YANG, PAN-CHYR, 王振源;陳冠宇;王振泰;陳人豪;林昭維;王鶴健;李麗娜;楊泮池   +1 more
core  

Volumetric Modulated Arc Therapy for lung cancer: Correlation between dose and volume

Journal of Applied Clinical Medical Physics, Volume 27, Issue 10, October 2026.
Abstract Background In lung cancer radiotherapy, the volume of the lung receiving a dose above 20 Gy (V20Gy) and the mean lung dose are widely recognized dosimetric indicators for predicting radiation pneumonitis. However, there is currently no unified model to predict the minimum achievable values of V20Gy and mean lung dose.
Yu Wang, Deying Xu, Yunfeng Liu, Xiaofeng Zhang, Liang Yu   +4 more
wiley   +1 more source

Forest plot of incidence of radiation pneumonitis.

, 2018
Forest plot of incidence of radiation pneumonitis.
Kwan-Il Kim (5318012), Ji Hee Jun (5318015), Beom-Joon Lee (5318009), Jae-Hyo Kim (5318018), Hee-Jae Jung (5318021), Hyunjung Baek (4447357)   +5 more
core   +1 more source

Myasthenia Gravis and Thymoma

Muscle &Nerve, Volume 74, Issue 4, Page 1156-1173, October 2026.
ABSTRACT Thymoma is the most common tumor of the anterior mediastinum. Approximately 20%–30% of patients with a thymoma develop myasthenia gravis (MG), and an additional one third may possess positive acetylcholine receptor (AChR) antibodies without MG.
Benjamin Claytor, Lukas Delasos, Daniel P. Raymond, Erik Seroogy, Jason Lempel, Yuebing Li   +5 more
wiley   +1 more source

A Single-Nucleotide Polymorphism in the Mthfr (Methylene Tetrahydrofolate Reductase) Gene Is Associated with Risk of Radiation Pneumonitis in Lung Cancer Patients Treated with Thoracic Radiation Therapy

, 2012
BACKGROUND: This study examined the association between functional single -nucleotide polymorphisms in candidate genes from oxidative stress pathways and risk of radiation pneumonitis (RP) in patients treated with thoracic radiation therapy for locally ...
LIU, CHEN-YU, 劉貞佑
core  

Ineffectiveness of immune checkpoint inhibitors in prostate cancer: is it just a question of ‘‐mabs’?

The Journal of Pathology, Volume 270, Issue 2, Page 139-162, October 2026.
Abstract Prostate cancer (PCa) is the second most common type of neoplasm, currently treated with a variety of therapeutic agents. Although advances in treatment over the past decade have improved overall survival, patients with advanced PCa eventually progress from hormone‐sensitive PCa to metastatic castration‐resistant PCa.
Giuseppe Schepisi, Irene Torresan, Emilio Francesco Giunta, Sara Bleve, Nicole Brighi, Elisa Tassinari, Sofia Zanuccoli, Maria Concetta Cursano, Cristian Lolli   +8 more
wiley   +1 more source

Dosimetric and radiobiological evaluations as well as technical aspects of left breast treatment employing DIBH with SGRT in radiotherapy with IMRT step and shoot, IMRT Dynamic MLC and VMAT

Journal of Applied Clinical Medical Physics, Volume 27, Issue 9, September 2026.
Abstract Background Treatment of the left breast using deep inspiration breath hold (DIBH), combined with surface guided radiotherapy (SGRT), has emerged as the standard for reducing the dose to the heart, the left anterior descending coronary artery (LAD), and the ipsilateral lung.
Julien Rolland, Stéphane Payan, Pierre Fau, Hugues Mailleux, Agnès Tallet   +4 more
wiley   +1 more source